MFDS — authorised 22 December 2008
- Marketing authorisation holder: LANTHEUS MEDCL
- Status: likely_approved
🇰🇷 GADOFOSVESET in South Korea
MFDS authorised GADOFOSVESET on 22 December 2008
Marketing authorisation
GADOFOSVESET in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is GADOFOSVESET approved in South Korea?
Yes. MFDS authorised it on 22 December 2008.
Who is the marketing authorisation holder for GADOFOSVESET in South Korea?
LANTHEUS MEDCL holds the South Korean marketing authorisation.